Hero MotoCorp Ltd has announced that production will be temporarily paused from April 17 to 19, 2025, at four of our ...

The Management has withdrawn the suspension of operations order and has instead declared lockout at Walchandnagar Industries ...

This week, much of the world got a re­prieve from Pres­i­dent Don­ald Trump’s tar­iffs. Drug­mak­ers might not be so for­tu­nate.

Another recommendation, also for experienced gardeners, is experimenting with self-seeding plants. Self-seeding annuals can be as reliable as perennials, coming back every year without being ...

Petscaping is a new term for designing outdoor landscapes with pet safety in mind. Many common plants, such as Sago palms and Coonties, are toxic to pets. Pet owners should research plants and ...

In India, it is the pharma sector that fits the bill. For a simple reason. While the Trump regime will make noises about tariffs on Indian pharma imports, the reality is that, given the poor state of ...

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px&apos ...

Drugmaker Natco Pharma on Tuesday said it intends to launch its generic version of spinal muscular atrophy drug Risdiplam only after and subject to successful clarity from the Appellate Bench of ...

A number of Indian generic drug manufacturers—including Dr Reddy’s Laboratories, Cipla, Natco Pharma and Alkem, among others—are working on generic versions of semaglutide, which is marketed in the US ...

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity. According to data from the BSE index, the ...

The drug modifies SMN2 gene splicing, improving motor neuron functionality. The plaintiffs, Roche, alleged that NATCO Pharma infringed their patent by initiating production of Risdiplam API (Active ...

Natco Pharma on Tuesday shared a legal update on the legal proceedings on the Risdiplam compound (used for treating spinal muscular atrophy) launch in India. "The company has received numerous ...